Aging and epigenetic drift: A vicious cycle

Journal of Clinical Investigation

Volumn 124, Issue 1, 2014, Pages 24-29

  Issa, Jean Pierre ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGING; CELL AGING; CELL FUNCTION; DNA METHYLATION; EMBRYO DEVELOPMENT; EPIGENETICS; GENE EXPRESSION; HISTONE MODIFICATION; HUMAN; MOSAICISM; NONHUMAN; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; REVIEW; STEM CELL;

EID: 84892909863     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI69735     Document Type: Review

References (85)

1. Waddington CH. The epigenotype. Endeavour. 1942; 1:18-20
2. Heard E, Clerc P, Avner P. X-chromosome inactivation in mammals. Annu Rev Genet. 1997;31:571-610
3. Barlow DP. Gametic imprinting in mammals. Science. 1995;270(5242):1610- 1613
4. Bird A. DNA methylation patterns and epigenetic memory. Genes Dev. 2002;16(1):6-21
5. Tan L, Shi YG. Tet family proteins and 5-hydroxymethylcytosine in development and disease. Development. 2012;139(11):1895-1902
6. Razin A, Riggs AD. DNA methylation and gene function. Science. 1980;210(4470):604-610
7. Li E, Beard C, Jaenisch R. Role for DNA methylation in genomic imprinting. Nature. 1993; 366(6453):362-365
8. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980;20(1):85-93
9. Lister R, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature. 2009;462(7271):315-322
10. Jones PA. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet. 2012;13(7):484-492
11. Jenuwein T, Allis CD. Translating the histone code. Science. 2001;293(5532):1074-1080
12. Sparmann A, van LM. Polycomb silencers control cell fate, development and cancer. Nat Rev Genet. 2006;6(11):846-856
13. Peters AH, et al. Partitioning and plasticity of repressive histone methylation states in mammalian chromatin. Mol Cell. 2003;12(6):1577-1589
14. Henikoff S, Shilatifard A. Histone modification: cause or cog? Trends Genet. 2011;27(10):389-396
15. Bird A. Perceptions of epigenetics. Nature. 2007; 447(7143):396-398
16. Badeaux AI, Shi Y. Emerging roles for chromatin as a signal integration and storage platform. Nat Rev Mol Cell Biol. 2013;14(4):211-224
17. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science. 1983; 220(4601):1055-1057
18. Wilson VL, Smith RA, Ma S, Cutler RG. Genomic 5-methyldeoxycytidine decreases with age. J Biol Chem. 1987;262(21):9948-9951
19. Fuke C, et al. Age related changes in 5-methylcytosine content in human peripheral leukocytes and placentas: an HPLC-based study. Ann Hum Genet. 2004;68(pt 3):196-204
20. Bollati V, et al. Decline in genomic DNA methylation through aging in a cohort of elderly subjects. Mech Ageing Dev. 2009;130(4):234-239
21. Figueiredo JC, et al. Global DNA hypomethylation (LINE-1) in the normal colon and lifestyle characteristics and dietary and genetic factors. Cancer Epidemiol Biomarkers Prev. 2009;18(4):1041-1049
22. Estecio MR, Issa JP. Tackling the methylome: recent methodological advances in genome-wide methylation profiling. Genome Med. 2009;1(11):106
23. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet. 1994;7(4):536-540
24. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JPJ. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res. 1998;58(23):5489-5494
25. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JPJ. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A. 1999;96(15):8681-8686
26. Waki T, Tamura G, Sato M, Motoyama T. Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene. 2003;22(26):4128-4133
27. Shibata D. Inferring human stem cell behaviour from epigenetic drift. J Pathol. 2009;217(2):199-205
28. Maegawa S, et al. Widespread and tissue specific age-related DNA methylation changes in mice. Genome Res. 2010;20(3):332-340
29. Beerman I, et al. Proliferation-dependent alterations of the DNA methylation landscape underlie hematopoietic stem cell aging. Cell Stem Cell. 2013;12(4):413-425
30. Hernandez DG, et al. Distinct DNA methylation changes highly correlated with chronological age in the human brain. Hum Mol Genet. 2011; 20(6):1164-1172
31. Christensen BC, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8):e1000602
32. Gronniger E, et al. Aging and chronic sun exposure cause distinct epigenetic changes in human skin. PLoS Genet. 2010;6(5):e1000971
33. Rakyan VK, et al. Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. Genome Res. 2010;20(4):434-439
34. Hannum G, et al. Genome-wide methylation profiles reveal quantitative views of human aging rates. Mol Cell. 2013;49(2):359-367
35. Horvath S, et al. Aging effects on DNA methylation modules in human brain and blood tissue. Genome Biol. 2012;13(10):R97
36. Lapeyre JN, Becker FF. 5-Methylcytosine content of nuclear DNA during chemical hepatocarcinogenesis and in carcinomas which result. Biochem Biophys Res Commun. 1979;87(3):698-705
37. Kren BT, Trembley JH, Steer CJ. Alterations in mRNA stability during rat liver regeneration. Am J Physiol. 1996;270(5 pt 1):G763-G777
38. Houseman EA, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86
39. Yoshihara K, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612
40. Shen L, et al. Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters. PLoS Genet. 2007;3(10):2023-2036
41. Feser J, Tyler J. Chromatin structure as a mediator of aging. FEBS Lett. 2011;585(13):2041-2048
42. O'Sullivan RJ, Karlseder J. The great unravelling: chromatin as a modulator of the aging process. Trends Biochem Sci. 2012;37(11):466-476
43. Liu L, et al. Chromatin modifications as determinants of muscle stem cell quiescence and chronological aging. Cell Rep. 2013;4(1):189-204
44. Maures TJ, Greer EL, Hauswirth AG, Brunet A. The H3K27 demethylase UTX-1 regulates C. elegans lifespan in a germline-independent, insulin-dependent manner. Aging Cell. 2011;10(6):980-990
45. Wood JG, et al. Chromatin remodeling in the aging genome of Drosophila. Aging Cell. 2010;9(6):971-978
46. Yates PA, Burman R, Simpson J, Ponomoreva ON, Thayer MJ, Turker MS. Silencing of mouse Aprt is a gradual process in differentiated cells. Mol Cell Biol. 2003;23(13):4461-4470
47. Rose JA, Yates PA, Simpson J, Tischfield JA, Stambrook PJ, Turker MS. Biallelic methylation and silencing of mouse Aprt in normal kidney cells. Cancer Res. 2000;60(13):3404-3408
48. Estecio MR, et al. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res. 2010;20(10):1369-1382
49. Feltus FA, Lee EK, Costello JF, Plass C, Vertino PM. Predicting aberrant CpG island methylation. Proc Natl Acad Sci U S A. 2003;100(21):12253-12258
50. Estecio MR, Gallegos J, Dekmezian M, Lu Y, Liang S, Issa JP. SINE retrotransposons cause epigenetic reprogramming of adjacent gene promoters. Mol Cancer Res. 2012;10(10):1332-1342
51. Takeshima H, Yamashita S, Shimazu T, Niwa T, Ushijima T. The presence of RNA polymerase II, active or stalled, predicts epigenetic fate of promoter CpG islands. Genome Res. 2009;19(11):1974-1982
52. Gravina S, et al. High preservation of CpG Cytosine methylation patterns at imprinted gene Loci in liver and brain of aged mice. PLoS One. 2013; 8(9):e73496
53. Hanawalt PC, Spivak G. Transcription-coupled DNA repair: two decades of progress and surprises. Nat Rev Mol Cell Biol. 2008;9(12):958-970
54. Boumber YA, et al. An Sp1/Sp3 binding polymorphism confers methylation protection. PLoS Genet. 2008;4(8):e1000162
55. Kerkel K, et al. Genomic surveys by methylationsensitive SNP analysis identify sequence-dependent allele-specific DNA methylation. Nat Genet. 2008;40(7):904-908
56. Talens RP, et al. Epigenetic variation during the adult lifespan: cross-sectional and longitudinal data on monozygotic twin pairs. Aging Cell. 2012; 11(4):694-703
57. Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001; 61(9):3573-3577
58. Eads CA, et al. Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. Cancer Res. 2000;60(18):5021-5026
59. Maekita T, et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin Cancer Res. 2006;12(3 pt 1):989-995
60. Shen L, et al. DNA methylation and environmental exposures in human hepatocellular carcinoma. J Natl Cancer Inst. 2002;94(10):755-761
61. Niwa T, et al. Inflammatory processes triggered by helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. Cancer Res. 2010;70(4):1430-1440
62. Hahn MA, et al. Methylation of polycomb target genes in intestinal cancer is mediated by inflammation. Cancer Res. 2008;68(24):10280-10289
63. Lu Y, Chu A, Turker MS, Glazer PM. Hypoxia-induced epigenetic regulation and silencing of the BRCA1 promoter. Mol Cell Biol. 2011;31(16):3339-3350
64. O'Hagan HM, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG islands. Cancer Cell. 2011;20(5):606-619
65. Mason JB. Biomarkers of nutrient exposure and status in one-carbon (methyl) metabolism. J Nutr. 2003;133(suppl 3):941S-947S.
66. Waterland RA, Jirtle RL. Transposable elements: targets for early nutritional effects on epigenetic gene regulation. Mol Cell Biol. 2003;23(15):5293-5300
67. Waterland RA, et al. Season of conception in rural gambia affects DNA methylation at putative human metastable epialleles. PLoS Genet. 2010;6(12):e1001252
68. Wallace K, et al. Association between folate levels and CpG Island hypermethylation in normal colorectal mucosa. Cancer Prev Res (Phila). 2010; 3(12):1552-1564
69. Spannhoff A, et al. Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees. EMBO Rep. 2011;12(3):238-243
70. Chuang JC, et al. Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine. Mol Cancer Ther. 2005;4(10):1515-1520
71. Estécio MR, et al. Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer. Genome Res. 2010; 20(10):1369-1382
72. Chambers SM, Shaw CA, Gatza C, Fisk CJ, Donehower LA, Goodell MA. Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. 2007;5(8):e201
73. Liu L, Rando TA. Manifestations and mechanisms of stem cell aging. J Cell Biol. 2011;193(2):257-266
74. Issa JP. Epigenetic variation and cellular Darwinism. Nat Genet. 2011;43(8):724-726
75. Zeki SS, Graham TA, Wright NA. Stem cells and their implications for colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011;8(2):90-100
76. Signer RA, Morrison SJ. Mechanisms that regulate stem cell aging and life span. Cell Stem Cell. 2013; 12(2):152-165
77. Richardson B. Primer: epigenetics of autoimmunity. Nat Clin Pract Rheumatol. 2007;3(9):521-527
78. Kim J, et al. Epigenetic changes in estrogen receptor beta gene in atherosclerotic cardiovascular tissues and in-vitro vascular senescence. Biochim Biophys Acta. 2007;1772(1):72-80
79. Post WS, et al. Methylation of the estrogen receptor gene is associated with aging and atherosclerosis in the cardiovascular system. Cardiovasc Res. 1999;43(4):985-991
80. Cancer Genome Atlas Research Network. Genomic epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med. 2013;368(22):2059-2074
81. Taby R, Issa JP. Cancer epigenetics. CA Cancer J Clin. 2010;60(6):376-392
82. Shih AH, Abdel-Wahab O, Patel JP, Levine RL. The role of mutations in epigenetic regulators in myeloid malignancies. Nat Rev Cancer. 2012; 12(9):599-612
83. Laird PW, et al. Suppression of intestinal neoplasia by DNA hypomethylation. Cell. 1995;81(2):197-205
84. Linhart HG, et al. Dnmt3b promotes tumorigenesis in vivo by gene-specific de novo methylation transcriptional silencing. Genes Dev. 2007; 21(23):3110-3122
85. Shen L, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst. 2005;97(18):1330-1338.